Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers includ... Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Show more
Pfizer Inc. (NYSE: PFE) today announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately. Mr. Taraporevala, age 57, was also appointed to and will join the...
The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older Recommendation is based on pre-clinical and...
Board of Directors approves quarterly cash dividend of $0.42 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 third-quarter 2024 dividend on the...
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EDT on Tuesday, July 30, 2024. The...
Fisker (NYSE:FSR) – The American electric vehicle manufacturer filed for bankruptcy last night, aiming to sell its assets and restructure debts following severe financial challenges in the...
Adobe (NASDAQ:ADBE) – Adobe exceeded expectations in the last quarter with revenue of $5.31 billion, above analysts’ consensus polled by FactSet of $5.29 billion. Adjusted earnings...
Patients in MagnetisMM-3 demonstrated a median overall survival (OS) of 24.6 months, with median progression-free survival (PFS) of 17.2 months Pfizer Inc. (NYSE: PFE) today announced detailed...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.58 | -2.04009848751 | 28.43 | 28.63 | 27.07 | 27895972 | 27.83880268 | CS |
4 | -1.45 | -4.94880546075 | 29.3 | 29.73 | 26.87 | 32810535 | 28.07625957 | CS |
12 | 1.08 | 4.03436682854 | 26.77 | 29.73 | 25.2 | 38405829 | 27.55929131 | CS |
26 | -1.04 | -3.59986154379 | 28.89 | 30.2788 | 25.2 | 40861287 | 27.591781 | CS |
52 | -8.67 | -23.7404162103 | 36.52 | 37.8 | 25.2 | 36258185 | 29.41533561 | CS |
156 | -11.64 | -29.4758166624 | 39.49 | 61.71 | 25.2 | 30318092 | 40.36437135 | CS |
260 | -15.83 | -36.2408424908 | 43.68 | 61.71 | 25.2 | 29739488 | 38.9943257 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.